Neulogy signs their first investments with two Slovakia-based startups. While Youcognize secured 200.000 euros, InHiro received an overall amount of 300.000 euros from both their parent company WebSupport and Neulogy Ventures.
InHiro – hiring heroes
The digital tool allows employers to create attractive job advertisements they can share on social networks in order to make the recruiting process as quick and easy as possible. Founded in April last year, their idea already won Neulogy’s annual StartupAwards.SK in 2013. Now InHiro secured a 300.000 euros investment which will help to “power up and broaden our team,” as Lucia, designer and co-founder of InHiro, pointed out. At the moment, InHiro’s objective is to expand and develop their networks and services: “The ultimate challenge is to go big with our idea and we’re really happy that Neulogy are with us on this mission,” stated Lucia optimistically.
The second beneficiary of Neulogy Venture Capital is Youcognize, an app that supports psychologists in caring for their clients. As featured in one of inventures’s recent startup picks, the app collects data on mood and behavior so psychologists keep informed about their clients’ condition solely by using their smartphones. Youcognize received their seed fund from an angel investor in November 2013 and now announced a 200.000 euros investment from Neulogy. To co-founder Milan Steskal, this Venture Capital was the best choice not only because they have experience in healthcare startups (e.g. diagnose.me, which was launched by Neulogy’s Ivan Stefunko) but also due to good connections to the US-market. “We will use the funding mostly on finishing and launching the product and enter the market in USA. […] We are launching on May 15th with our launch partner, The Flatwater Foundation,” explained Steskal.
Two new funds for “global companies”
Recently, the Bratislava-based Neulogy Venture announced two new investment funds. The seed funds will support start ups from the very beginning and are backed up by European Investment Fund as well as private investors. The team consists of Michaela Jacova, Christian Mandl, Jaroslav Lupták and Ivan Stefunko and will allocate the overall 23 million Euro of assets to projects in the area of technology, communication, medical diagnosis and want to “help entrepreneurs build global companies”.